SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid renewed discussions around the release of Epstein files and their potential implications for Donald Trump. The community is actively debating the significance of newly released emails and their connection to Trump, with some questioning his past associations and others dismissing the concerns as politically motivated. Broader conversations encompass topics like digital IDs, the economy, and the influence of political figures.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending as investors digest mixed signals from earnings, including strong revenue growth but a Q3 miss, while also weighing future government contracts and the significance of antimony in critical minerals. The community is actively discussing the potential for future growth, the impact of government funding, and the company's strategic positioning amidst global supply chain concerns. Bullish sentiment remains, centered around long-term prospects and UAMY's role in securing domestic mineral supply.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax ($NVAX) is trending due to Shah Capital's renewed push for a company sale, citing dissatisfaction with management's performance and capital allocation, leading to investor concerns about operational inefficiencies. The community is discussing potential proxy fights and expressing frustration with the lack of communication from Novavax leadership regarding a potential deal or partnership. Investors are also weighing the potential of Novavax's Matrix-M adjuvant technology and upcoming catalysts, such as Sanofi partnership milestones, against ongoing concerns about cash burn and potential dilution.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending downwards, driven by investor concerns around debt financing for AI infrastructure and recent analyst downgrades. Community sentiment is largely bearish, with discussions focusing on the lack of management response to the stock's decline and speculation about a potential AI bubble. Some traders are looking for a potential bounce, while others are questioning the company's valuation and future prospects.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending following earnings, with community chatter focused on AI-driven growth and margin strength. Despite a slightly cautious outlook, the company's raised full-year guidance and AI infrastructure orders are fueling bullish sentiment. Some see parallels to the dot-com era, while others anticipate further upside based on AI tailwinds and potential analyst upgrades.

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

Korro Bio (KRRO) is trending amid discussions around its recent stock performance and potential opportunities, following a significant drop. Bullish investors are eyeing potential bounce plays, citing institutional ownership and cash reserves, while others point to risk factors from the latest 10-Q filing and pivot in R&D.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending due to recent news of a major institutional investor, Deep Track Capital, taking a significant stake in the company. The community views this as a strong bullish signal, anticipating potential upside driven by upcoming catalysts such as the NYC skin disease summit and an FDA meeting in December. Discussions also revolve around a potentially tightening float and possible short squeeze.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly (DPRO) is trending amid discussions about a new partnership and its participation in the AUSA Annual Meeting & Exposition. The community is actively discussing the company's potential in the defense sector, especially regarding drone technology for the U.S. Army, as well as speculation about the impact of new contracts on revenue growth and profitability.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors anticipate upcoming earnings, with community discussions focusing on streaming profitability and potential catalysts. The ongoing dispute with YouTube TV regarding channel distribution and subscription costs also remains a key talking point. Recent box office performance and theme park strategies are being weighed against broader market trends.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Recent earnings have sparked volatility in Firefly Aerospace ($FLY), with the community debating whether a significant drop is justified or if the stock is oversold. Bulls highlight the company's backlog and potential for future growth tied to government contracts like Golden Dome, while bears point to current financial losses and a recent rocket test failure. Community members are actively discussing entry points, potential price targets, and the impact of upcoming news and contract announcements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Theravance Biopharma (TBPH) Q3 Earnings and Revenues Beat Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of +233.33% and +2.08%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -77.78% and +4.75%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy

IGC Pharma, Inc. (IGC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Best Momentum Stocks to Buy for Oct. 24

ASM, IGC and RY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 24, 2025.

New Strong Buy Stocks for Oct. 24: IGC, ASM and More

IGC, SCRYY, RY, UVE and ASM have been added to the Zacks Rank #1 (Strong Buy) List on Oct. 24, 2025.

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +33.33% and -0.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates

Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates

Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +102.86% and +154.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates

IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50.00% and +6.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

IGC Pharma Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

IGC
IGC Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IGC News

IGCIGC Pharma Inc